Search Form
First, enter a politician or zip code
Now, choose a category
 

Claire McCaskill's Public Statements on Issue: Drugs

Office: U.S. Senate (MO) - Sr, Democratic
Date Title
Sept. 12, 2017 McCaskill Continues Investigation Into Opioid Crisis with Committee Roundtable on Opioids Sales and Marketing
Sept. 6, 2017 McCaskill Opioid Investigation Releases First Report Detailing Systemic Manipulation of Prior Authorization Process by Insys Therapeutics
Aug. 7, 2017 Naloxone Access, Affordability Is Focus of McCaskill Inquiry
Aug. 2, 2017 Letter to Seamus Mulligan, CEO of Adapt Pharmaceuticals, Jack Y. Zhang, CEO of Amphastar Pharmaceuticals, Spencer Williamson, CEO of Kaleo Pharma, and Ian C. Read, CEO of Pfizer - Price of Naloxone
July 27, 2017 BREAKING: McCaskill Opioid Investigation Expands to Include Distributors and Additional Manufacturers
July 26, 2017 McCaskill's Bipartisan Bill to Combat Drug and Weapons Trafficking Unanimously Passes Key Committee
July 25, 2017 Springfield, Greene County Approve Prescription Drug Monitoring Programs--McCaskill Statement
July 17, 2017 McCaskill on Governor's Prescription Drug Monitoring Announcement
July 14, 2017 Stopping Illegal Opioids from Entering the U.S. Is Focus of McCaskill-Backed Bipartisan Bill
July 11, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
June 28, 2017 Food and Drug Administration Announces Action Plan that Mirrors Collins, McCaskill, Cotton, Franken Bipartisan Bill to Lower Cost of Prescription Drugs
June 13, 2017 Highlighting Bipartisan Plan to Lower Cost of Prescription Drugs, McCaskill, Collins Praise Food and Drug Administration Chief's Remarks
June 2, 2017 Following McCaskill Request, Department of Justice Inspector General to Investigate Opioid Enforcement
May 31, 2017 McCaskill Targets Opioid Shipments from China During Senate Hearing
May 31, 2017 McCaskill Targets Opioid Shipments from China During Senate Hearing
May 23, 2017 After Pressure from McCaskill, Administration Backs Off Proposal to Eliminate Office of National Drug Control Policy
May 19, 2017 Given Impact on Missouri if National Drug Effort Eliminated, McCaskill Urges Administration to Fund Program
May 17, 2017 McCaskill to Greitens: Special Session Needed to Combat Missouri's Opioid Epidemic
May 13, 2017 McCaskill: "Bitterly disappointed' Jefferson City Fails Once Again on Prescription Drug Monitoring Program
May 12, 2017 McCaskill to Trump: "I'm committed to working with you' to Curb Opioid Epidemic
May 11, 2017 McCaskill, Collins Effort to Tackle Cost of Rx Drugs Clears Key Committee Hurdle
May 9, 2017 McCaskill, Johnson Ask DEA for Information Regarding Drug Diversion
May 8, 2017 Letter to Charles Rosenberg, Acting Administrator of the Drug Enforcement Administration - Information Regarding Drug Diversion
May 8, 2017 Creating Generic Competition for Prescription Drugs is Aim of McCaskill-backed Bipartisan Effort
April 11, 2017 Continuing Support for Prescription Drug Monitoring Program, McCaskill Advocates for County-Level Funding
April 5, 2017 Missouri Senate Must Pass Prescription Drug Monitoring Bill, McCaskill Urges
March 29, 2017 McCaskill Statement on Chris Christie Leading White House Addiction Commission
March 28, 2017 Opioid Manufacturers are Subject of New McCaskill-Led, Wide-Ranging Investigation
March 6, 2017 Letter to Michael Horowitz, Inspector General - Requesting Investigation into Opioid Distributor Enforcement
Feb. 6, 2017 Continuing Work to Combat Opioid Epidemic, McCaskill Meets With Missouri Prosecutors
Jan. 26, 2017 Prescription Drug Monitoring Funds Now Available to Missouri Counties & Cities Following McCaskill Efforts
Jan. 23, 2017 Columbia Moves to Establish City Prescription Drug Monitoring Program--McCaskill Statement
Jan. 11, 2017 BREAKING: Missouri Counties Can Now Get Funding for Local Prescription Drug Monitoring Programs Thanks to McCaskill Efforts
Sept. 20, 2016 McCaskill Announces Resource and Information Page During Prescription Opioid and Heroin Epidemic Awareness Week
Sept. 14, 2016 Bipartisan Group of Senators Respond to Report Showing that 20% of Medicare Generic Drugs Have More Than Doubled in Price
Sept. 6, 2016 $5 Million Opioid Treatment, Prevention Grant is Great News for Missouri -- McCaskill
Aug. 8, 2016 McCaskill Seeks Answers on Administration Efforts to Monitor Opioid Prescribers
Aug. 4, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request Update on DEA Efforts to Monitor Controlled Substances Prescribers
Aug. 2, 2016 Letter to The Honorable Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services - Urging CMS to Expand Substance Abuse Treatment Coverage
July 22, 2016 In Columbia, Solutions to Combat Nation's Opioid Epidemic are Focus of McCaskill-Vilsack Town Hall
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
July 13, 2016 McCaskill Delivers for Missouri on Federal Legislation Combatting Opioid Epidemic
June 21, 2016 Bipartisan Senators Comment on Deficiencies in Monitoring Eligibility of Controlled Substance Prescribers
June 7, 2016 McCaskill Seeks Drug Pricing Information on Opioid Overdose Reversal Drugs
June 6, 2016 Chairman Collins, Ranking Member McCaskill Seek Information from Companies on Efforts to Preserve Accessibility of Opioid Overdose Reversal Drug
May 13, 2016 McCaskill Statement on Opening Defense Bill Debate to the Public
May 13, 2016 KOLR (CBS Springfield) - Prescription Drug Monitoring Bill Dies In Missouri Legislature
April 27, 2016 Hearing of the Senate Aging Committee - Sen. McCaskill's Opening Statement on "Valeant Pharmaceuticals' Business Model: the Repercussions for Patients and the Health Care System"
April 13, 2016 McCaskill Drills Down on Wasteful Spending in Central, South American Counternarcotics Efforts
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top